Venlafaxine hydrochloride
Venlafaxine Hydrochloride is a generic prescription antidepressant that helps balance brain chemicals like serotonin and norepinephrine to treat depression and anxiety. It comes as extended-release oral capsules in 37.5 mg, 75 mg, and 150 mg strengths, manufactured by Zydus Pharmaceuticals USA Inc. (ANDA090174). This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Venlafaxine Hydrochloride is a generic prescription antidepressant that helps balance brain chemicals like serotonin and norepinephrine to treat depression and anxiety. It comes as extended-release oral capsules in 37.5 mg, 75 mg, and 150 mg strengths, manufactured by Zydus Pharmaceuticals USA Inc. (ANDA090174). This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Venlafaxine hydrochloride",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Venlafaxine hydrochloride — ANDA 077653 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077653"
}
]
|
| identifier | ANDA077653 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"health-care",
"medications",
"pharmaceuticals",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Venlafaxine hydrochloride |
